Matinas BioPharma Holdings (MTNB) Goodwill (2015 - 2024)

Matinas BioPharma Holdings (MTNB) has 10 years of Goodwill data on file, last reported at $1.3 million in Q3 2024.

• Goodwill for Q3 2024 came in at $1.3 million, changed 0.0% year-over-year; the trailing twelve-month figure through Sep 2024 was $1.3 million (changed 0.0% YoY), and the FY2023 annual result was $1.3 million, changed 0.0% from the prior year.
• Goodwill steadied at $1.3 million in Q3 2024 per MTNB's latest filing, from $1.3 million in the prior quarter.
• Over five years, Goodwill peaked at $1.3 million in Q1 2020 and troughed at $1.3 million in Q4 2021.
• A 5-year average of $1.3 million and a median of $1.3 million in 2020 frame the typical range for Goodwill.
• The sharpest annual moves came in 2020 and 2021: Goodwill changed 0.0% in 2020, then declined 0.04% in 2021.
• A 5-year view of Goodwill shows it stood at $1.3 million in 2020, then dropped by 0.04% to $1.3 million in 2021, then changed by 0.0% to $1.3 million in 2022, then changed by 0.0% to $1.3 million in 2023, then changed by 0.0% to $1.3 million in 2024.
• Business Quant data shows MTNB's Goodwill at $1.3 million in Q3 2024, $1.3 million in Q2 2024, and $1.3 million in Q1 2024.